ORKA

Oruka Therapeutics, Inc. Common Stock
ORKA

Overview Fund Activity

71 hedge funds and large institutions have $326M invested in Oruka Therapeutics, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 28 increasing their positions, 12 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
71
Holders Change
+5
Holders Change %
+7.58%
% of All Funds
0.96%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
16
Increased
28
Reduced
12
Closed
10
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
+$2K

Top Buyers

1
VA
1
VR Adviser
New York
$42.6M
2
DTC
2
Deep Track Capital
Connecticut
$14.8M
3
Blackstone Inc
3
Blackstone Inc
New York
$8.04M
4
PCH
4
Polar Capital Holdings
United Kingdom
$10.8M
5
B
5
Braidwell
Connecticut
$16.1M

Top Sellers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$0
2
PA
2
Perceptive Advisors
New York
$0
3
PBA
3
Paradigm Biocapital Advisors
New York
$0
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$4.22M
5
DCM
5
Driehaus Capital Management
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Adage Capital Partners
76
Adage Capital Partners
Massachusetts
– -$1.34M -69,200 Closed
6CM
77
683 Capital Management
New York
– -$657K -33,875 Closed
Ensign Peak Advisors
78
Ensign Peak Advisors
Utah
– -$485K -25,000 Closed
Jane Street
79
Jane Street
New York
– -$343K -17,706 Closed
ACM
80
Aster Capital Management
United Arab Emirates
– -$97 -5 Closed
1 2 3
4